Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A Systematic Review

Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A Systematic Review

Immune checkpoint inhibitors (ICIs) have significantly transformed cancer treatment, but their use is linked to immune-related adverse events (irAEs), including the rare ICI-associated myocarditis, myositis, and myasthenia gravis (MMM) overlap syndrome. This systematic review aims to highlight MMM’s...

Full description

Bibliographic Details
Main Authors: Demis N. Lipe, Aiham Qdaisat, Pavitra P. Krishnamani, Trung D. Nguyen, Patrick Chaftari, Nour El Messiri, Aswin Srinivasan, Elkin Galvis-Carvajal, Cielito C. Reyes-Gibby, Monica K. Wattana
Format: Article
Language:English
Published: MDPI AG 2024-08-01
Series:Diagnostics
Subjects:
immunotherapy
immune-related adverse events
myasthenia gravis
myocarditis
myositis
immune checkpoint inhibitors
Online Access:https://www.mdpi.com/2075-4418/14/16/1794

Internet

https://www.mdpi.com/2075-4418/14/16/1794

Similar Items